ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO0960

Papillary Epithelial Proliferations in Inherited Cystic Kidney Diseases: A Clinicopathologic Consecutive Series Evaluation

Session Information

Category: Pathology and Lab Medicine

  • 1800 Pathology and Lab Medicine

Authors

  • Tanaka, Kara, University of California San Francisco, San Francisco, California, United States
  • Wu, Douglas, Stanford University, Stanford, California, United States
  • Williamson, Sean R, Cleveland Clinic, Cleveland, Ohio, United States
  • Chan, Emily, Stanford University, Stanford, California, United States
  • Sangoi, Ankur, Stanford University, Stanford, California, United States
Background

Small intracystic epithelial proliferations (hereafter referred to as “papillary epithelial proliferations” (PEP)) have been described in concert with other atypical renal cysts (ARC) or neoplastic renal lesions, however, complete clinicopathologic assessment and incidence of PEP in hereditary polycystic kidney disease is not yet known.

Methods

Consecutive nephrectomies for autosomal dominant (ADPKD) or autosomal recessive polycystic kidney disease (ARPKD) were reviewed for evaluation of PEP, defined as tufted or papillary intracystic growths covered by a single layer of cuboidal cells with minimal amphophilic cytoplasm and low-grade nuclei [Fig. 1]. Lesions with clear cells or multilayering were excluded. Features of PEP were recorded: number of cysts with PEP, size of most prominent PEP per case (height, width, size of cyst containing PEP), architecture, and cytology.

Results

49 nephrectomies (34 ADPKD, 15 ARPKD) from 29 patients (20 bilateral) demonstrated PEP in 60% (28/47) of kidneys, with higher incidence in ADPKD (84%, 27/32) vs ARPKD (7%, 1/15). Architectural patterns included tufted (97%), papillary (73%), hobnail (63%), micropapillary (63%), and hierarchical branching (10%). Amphophilic (97%) and eosinophilic cytoplasm (37%) were seen. The most well-developed PEP per case measured on average 0.3 x 2.1 mm (height x width) and were present in cysts averaging 3 mm in diameter.

Conclusion

PEP are common microscopic findings in nephrectomies from patients with ADPKD and, less frequently, ARPKD. While a subset of kidneys with PEP also showed neoplastic lesions (2/29, 7%) or ARC, we hypothesize that PEP are likely reactive rather than neoplastic. Immunohistochemical and molecular characterization is ongoing to further evaluate PEP.

Digital Object Identifier (DOI)